|1.||Maletz, Sibylle X: 1 article (01/2014)|
|2.||Simon, Anne: 1 article (01/2014)|
|3.||Schäffer, Andreas: 1 article (01/2014)|
|4.||Hollert, Henner: 1 article (01/2014)|
|5.||Maes, Hanna M: 1 article (01/2014)|
|6.||Tralau, Tewes: 1 article (08/2013)|
|7.||Tarnow, Patrick: 1 article (08/2013)|
|8.||Luch, Andreas: 1 article (08/2013)|
|9.||Hunecke, Danele: 1 article (08/2013)|
|10.||Drugeon, H-B: 1 article (06/2012)|
10/01/2002 - "The routine use of triclocarban-containing soap by children living in a community with a high incidence of impetigo was associated with a reduced incidence of impetigo."
10/01/2002 - "We conducted a study to determine if soap containing 1.2% triclocarban would be effective in reducing the incidence of impetigo. "
10/01/2002 - "After adjustment for household clustering and covariates, the incidence of impetigo among children living in households receiving triclocarban-containing soap (1.10 episodes per 100 person-weeks) was 23% lower than in households receiving placebo soap (P = 0.28) and 43% lower than the standard habit and practice controls (P = 0.02). "
06/01/2012 - "Triclocarban remains still very effective for the treatment of either initially bacterial skin and mucosal infections, or skin and mucosal at risk of super infection."
03/25/1989 - "[Importance of an antiseptic solution, Solubacter, in vulvo-vaginal infections]."
10/01/1985 - "Septivon-Lavril is bactericidal in vitro towards species of mycoplasmas responsible for vaginal infections and their complications (U. "
|3.||Wounds and Injuries (Trauma)
03/25/1989 - "Solubacter was prescribed, in combination with etiological treatment, for local application in 275 women with vulvovaginitis by 19 gynecologists in general practice as part of an open, multicentre study. "
03/25/1989 - "Solubacter thus proved to be a suitable additional aid in the treatment of vulvovaginitis."
01/01/2014 - "Three different cell lines (rainbow trout liver cells (RTL-W1), human adrenocortical carcinoma cells (T47Dluc), and human adrenocarcinoma cells (H295R)) were exposed to multiwalled carbon nanotubes, the antimicrobial agent triclocarban (TCC) as well as the mixture of both substances in a concentration range of 3.13 to 50 mg CNT/L, 31.25 to 500 μg TCC/L, and 3.13 to 50 mg CNT/L + 1% TCC (percentage relative to carbon nanotubes concentration), respectively. "
|3.||chlorhexidine gluconate (Dyna-Hex)
|4.||Carbon Nanotubes (Carbon Nanotube)
|5.||Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)
|8.||Anti-Infective Agents (Microbicides)